| ¼ò½é£º   
	²¿·ÝÖÐÎÄ·Ç´ïÃ¹ËØ´¦·½×ÊÁÏ£¨½ö¹©²Î¿¼£©Ó¢ÎÄÃû£ºfidaxomycin
 ÉÌÆ·Ãû£ºDafclir Tablets
 ÖÐÎÄÃû£º·Ç´ïÃ¹ËØÆ¬
 Éú²úÉÌ£º°²Ë¹Ì©À´ÖÆÒ©
 Ò©Æ·½éÉÜ
 ½üÈÕ£¬Óɰ²Ë¹Ì©À´ÖÆÒ©¿ª·¢µÄ´«È¾ÐÔ³¦Ñ׵ĿڷþƬ¼Áfidaxomycin£¨ÉÌÆ·Ãû Dafclir  ¥À¥Õ¥¯¥ê¥¢åV £©ÒÑ»ñµÃÈÕ±¾Åú×¼ÉÏÊУ¬ÓÃÓÚÖÎÁÆ´«È¾ÐÔ³¦Ñ×£¬¼ÙĤÐԽ᳦Ñס£
 ¥À¥Õ¥¯¥ê¥¢åV200mg
 Ò©Îï·ÖÀàÃû³Æ
 ¼èÄÑËó¾ú¸ÐȾÖÎÁÆ
 Åú×¼ÈÕÆÚ£º2018Äê8ÔÂ
 É̘ËÃû
 Dafclir Tablets 200mg
 Ò»°ãÃû
 ¥Õ¥£¥À¥¥½¥Þ¥¤¥·¥ó£¨Fidaxomicin£©
 ÂÔºÅ
 FDX
 »¯Ñ§Ãû
 £¨3E,5E,8S,9E,11S,12R,13E,15E,18S£©-3-£¨{[6-Deoxy-4-O-£¨3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl£©-2-O-methyl-β-D-mannopyranosyl]oxy}methyl£©-12-{[6-deoxy-5-C-methyl-4-O-£¨2-methylpropanoyl£©-β-D-lyxo-hexopyranosyl]oxy}-11-ethyl-8-hydroxy-18-[£¨1R£©-1-hydroxyethyl]-9,13,15-trimethyloxacyclooctadeca-3,5,9,13,15-pentaen-2-one
 ˜‹Ôìʽ
 ·Ö×Óʽ
 C52H74Cl2O18
 ·Ö×ÓÁ¿
 1058.04
 ÈÚµã
 177¡«180¡æ
 ·ÖÅä‚SÊý
 3.7
 ÐÔ×´
 ·Ç´ïÃ¹ËØÊǰ×É«·ÛÄ©¡£Ò×ÈÜÓÚËÄÇâ߻ૣ¬¶þ¼×»ùÑÇí¿ºÍ¼×´¼£¬Î¢ÈÜÓÚ±ûͪ£¬Î¢ÈÜÓÚÒÒËáÒÒõ¥£¬ÒÒ´¼£¨99.5£©£¬¶þÂȼ×ÍéºÍÒÒëæ£¬ÈÜÓÚÒì±û´¼£¬²»ÈÜÓÚBritton-Robinson»º³åÒº£¨pH 8£©¼¸ºõ²»ÈÜÓÚBritton-Robinson»º³åÒº£¨pH 4,6ºÍ7£©¡£
 Åú×¼Ìõ¼þ
 ÖÆ¶¨Ò©Æ··çÏÕ¹ÜÀí¼Æ»®²¢Êʵ±ÊµÊ©¡£
 Ò©ÓÃÒ©Àíѧ
 1.¿¹¾ú×÷ÓÃ
 ·Ç´ïÃ¹ËØ¶Ô°üÀ¨¼èÄÑËó¾úÔÚÄÚµÄһЩ¸ïÀ¼ÊÏÑôÐÔ¾ú¾ßÓп¹¾ú»îÐÔ£¬²¢ÇÒ¶Ô´ó¶àÊý¸ïÀ¼ÊÏÒõÐÔ¾úûÓÐÏÔʾ³ö¿¹¾ú»îÐÔ¡£
 2.×÷ÓûúÖÆ
 ͨ¹ýÒÖÖÆÏ¸¾úRNA¾ÛºÏø£¬ËüÏÔʾ³ö¿¹¾ú»îÐÔ¡£
 ÊÊÓ¦Ö¢
 <Õæ¾úÖÖÀà>
 ¼èÄÑËó¾ú¶Ô¸ÃÒ©Ãô¸Ð
 <ÊÊÓ¦Ö¢>
 ´«È¾ÐÔ³¦Ñ×£¨°üÀ¨Î±Ä¤ÐԽ᳦Ñ×£©
 Ó÷¨ÓëÓÃÁ¿
 ³ÉÈË£»Ã¿ÌìÒ»´Î£¬Ã¿´Î¿Ú·þ200mg¡£
 °ü×°
 Ƭ¼Á
 200ºÁ¿Ë£º20Ƭ£¨10Ƭx 2£©
 
  ÖÆÔìÏúÊÛ
 °²Ë¹Ì©À´ÖÆÒ©¹«Ë¾
 ×¢£ºÒÔÉÏÖÐÎÄ×ÊÁϲ»¹»ÍêÕû£¬Ê¹ÓÃÕßÒÔÔ´¦·½×ÊÁÏΪ׼¡£
 ÍêÕû´¦·½×ÊÁϸ½¼þ£º
 https://www.info.pmda.go.jp/go/pack/6119001F1025_1_02/?view=frame&style=SGML&lang=ja
 Dafclir Tablets 200mg£¨Fidaxomicin£©
 Brand name:Dafclir Tablets 200mg
 Active ingredient:Fidaxomicin
 Dosage form:pale yellow red tablet, major axis: approx. 13.1 mm, minor axis:approx. 7.0 mm, thickness : approx. 5.1 mm
 Print on wrapping:(Face) ¥À¥Õ¥¯¥ê¥¢ 200 mg, house-mark,(Back) ¥À¥Õ¥¯¥ê¥¢ 200 mg, ¸ÐȾÐÔÄcÑ×ÖίŸ„ˆ, house-mark
 Effects of this medicine
 This medicine suppresses RNA polymerase necessary for bacterial growth and shows antibactrial activities.
 It is usually used for the treatment of infectious enterocolitis (including pseudomembranous colitis) by Clostridiumdifficile.
 Before using this medicine, be sure to tell your doctor and pharmacist
 ・If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
 ・If you are pregnant or breastfeeding.
 ・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinaleffects.Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines)
 Dosing schedule (How to take this medicine)
 ・Your dosing schedule prescribed by your doctor is(( to be written by a healthcare professional))
 ・In general, for adults, take 1 tablet (200 mg of the active ingredient) at a time, twice a day. Strictly follow theinstructions.
 ・If you miss a dose, please take immediately when you notice. However, if it is almost time for the next dose, skip themissed dose and continue your regular dosing schedule. Do not take two tablets at once.
 ・If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
 ・Do not stop taking this medicine unless your doctor instructs you to do so.
 Precautions while taking this medicine
 Possible adverse reactions to this medicine
 The most commonly reported adverse reactions include constipation, nausea, and vomiting. If any of these symptomsoccur, consult with your doctor or pharmacist.
 The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicatedin brackets. If any of these symptoms occur, stop taking this medicine and see your doctorimmediately.
 ・rash, itching, angioedema, dyspnea [anaphylaxis]
 The above symptoms do not describe all the adverse reactions to this medicine. Consult with yourdoctor or pharmacist if you notice any symptoms of concern other than those listed above.
 Storage conditions and other information
 ・Keep out of the reach of children. Store away from direct sunlight, heat and moisture.
 ・Discard the remainder. Do not store them.
 Internal
 Published: 08/2018
 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approvaldetails may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It isimportant to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response,patients should understand their medication and cooperate with the treatment.
 |